Treating androgen decline in aging male (adam)-associated conditions with sarms
CA 2501874 A1 · Owner: Dalton, James T. · Inventors: Dalton, James T.; Veverka, Karen A.; Miller, Duane D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of treating preventing, suppressing, inhibiting or reducing the incidence of an Androgen Decline in Aging Male (ADAM)~- associated condition in a male subject by administering to the , subject a selective androgen receptor modulator (SARM) compound and/or its analog, derivative, isomer, metabolite pharmaceutically acceptable salt, pharmaceutical product hydrate, N-oxide, prodrug, polymorph, crystal or any , combination thereof. The present invention further provides a method of treating, preventing, suppressing, inhibiting or reducing the incidence of sexual dysfunction, decreased sexual libido erectile dysfunction, hypogonadism, sarcopenia …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.